drugset
drugset / Trial / NCT00853229

Pregabalin for the Treatment of Vulvodynia

NCT00853229 ↗

Phase 2 Terminated 16 enrolled The Cleveland Clinic
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to determine whether pregabalin is effective in the treatment of vulvodynia.

Timeline

Start
2009-02
Primary completion
2013-04
Completion
2013-04

Outcome

Outcome not reported

Stopped (Enrollment): “Not feasible due to low accrual”

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 150 mg —

Indications

vulvitis vulvodynia